Outcomes Of Systemic Therapy In Relapsed Renal Cell Carcinoma (Rcc) Treated With Adjuvant Sunitinib (As)
JOURNAL OF CLINICAL ONCOLOGY(2020)
摘要
701Background: There are no available data on the usefulness of targeted therapy (TT) as the first-line treatment for patients with RCC recurrence after AS. We aim to explore the outcomes of system...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要